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Abstract
Background and Objective: In recent years, there has been an increasing interest in discovering the role of plasmids in emerging
fluoroquinolones resistance implicated in serious difficulties of nosocomial infections’ therapy. Therefore, this  study  aimed  to  explore
the  association  of  Pseudomonas  aeruginosa  plasmid  DNA  in  emerging  fluoroquinolone resistance. Materials and Methods: Thirty
P. aeruginosa  isolates were diagnosed in 45 specimens collected from patients with infected burns who attended the local hospitals in
Baghdad. Antibiotic susceptibility of the studied isolates to different fluoroquinolones (ciprofloxacin, levofloxacin, norfloxacin and
ofloxacin) has been investigated and showed variable responses. Plasmid DNA profiles of P. aeruginosa  cells were also investigated
utilizing QIAprep Spin Miniprep Kit and distinguished by agarose gel electrophoresis. In order to investigate the association between the
fluoroquinolone resistant isolates and their content of plasmid DNA, two strategies were adopted: (1) SDS-based plasmid curing technique
and (2) Bacterial transformation by plasmid DNA. Results: The results illustrate that the plasmid elimination from P. aeruginosa  progeny
cells has slightly increased fluoroquinolones response in comparison to the parental cells and Ciprofloxacin was the more susceptible
antibiotic to P. aeroginosa. Further evidence was obtained from transformation of TOP10  Escherichia  coli  by P. aeruginosa  extracted
plasmids. Transformed E. coli  cells exhibited resistance to some of the fluoroquinolones (Ciprofloxacin). Conclusion: The findings
suggested that P. aeruginosa  plasmid content could be a preliminary determinant for fluoroquinolone-based therapeutic regimens of
nosocomial infections caused by P. aeruginosa.
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INTRODUCTION
Pseudomonas aeruginosa is a leading nosocomial
pathogen causing an emergence of multidrug resistance1 and
thus higher rates of nosocomial mortalities, especially in
hospitalized burn individuals2. Beside their use in treating a
variety of bacterial infections, such as respiratory, urinary tract
and joint and bone infections, typhoid fever, septicaemia,
bacterial gastroenteritis and gynecological infections3,4,
fluoroquinolones are widely administrated to treat burn-
related infections caused by P. aeruginosa  alongside with
other drugs of choice5. Nonetheless, emergence of
fluoroquinolones-resistant strains of P. aeruginosa  represents
a serious growing medical problem that challenges their
clinical use6,7. Mutations in drug efflux pumps regulated genes
as  well  as  DNA  gyrase  and  topoisomerase  IV  encoding
genes, gyrA and parC, respectively, are the main molecular
mechanisms leading to fluoroquinolones resistance in these
pathogenic bacteria8. It is well established that these
mechanisms are chromosomally regulated9. However, recent
years witnessed growing evidence about the fluoroquinolone
regulated  genes  carried  by  extra  chromosomal plasmid
DNA   in   nosocomial   Enterobacteria   members10,  in
particular  Klebsiella  pneumonia   and  Eschirechia  coli11,12.
However, a modicum is reported regarding the relation
between the plasmid content of nosocomial P. aeruginosa
regarding emergence of their antimicrobial resistance to
fluoroquinolones13,14. In addition, the available evidence was
even ambiguous in terms of determination the direct link
between  nosocomial  P. aeruginosa  plasmids  and  their
response to the fluoroquinolones15. Since exploring such
association, which may stand behind decreasing the
fluoroquinolone cellular response of P. aeruginosa,  represents
unmet  clinical  need  particularly  in  Iraqi  hospitals,  the  aim
of this study was, therefore, to investigate the plasmid
implication in emergence of fluoroquinolones resistance in
nosocomial isolates of P. aeruginosa.
MATERIALS AND METHODS
Sample collection and bacterial isolation: This study has
been conducted within one year of time starting from
September, 2017. In order to explore the nosocomial
infections with P. aeruginosa,  two hospitals located in
Baghdad (AL-Yarmook Teaching Hospital and Imamein
Kadhimein Medical city) were targeted in this research. Forty
five clinical samples had been autonomously collected from
individuals  with  infected  burn  wounds.  The   samples   were
stored in the hospitals’ laboratories, where they obtained
from. The collection was performed during the period of
5\12\2016-18\2\2017. Accordingly, no ethical approval was
needed since the routine microbiological investigation was
taken place in the hospitals’ laboratories.
Bacterial diagnosis: The selective condition of 42EC overnight
incubation on 0.3% Cetrimide agar was applied for the
preliminary  detection.  A  single  isolated  colony  of  each
isolate  was  subjected  for  confirmative  routine  diagnosis  of
P. aeruginosa by conducting; (1) Oxidase (10 mg mLG1
tetramethyl para phenylenediamine dihydrochloride) and
Catalase (3% hydrogen peroxide) tests and (2) Biochemical
tests based on the principles of microbiological techniques16.
Antimicrobial susceptibility: The examined isolates were
tested for investigating their antimicrobial response using disc
diffusion method and Minimal Inhibitory Concentrations
(MICs). Inocula taken from overnight grown colonies of
examined isolates were suspended in PBS buffer and adjusted
in accordance to 0.5 Mc Farland standard to obtain
approximate rate of 1.5×10 CFU mLG1. About 0.1 mL of
bacterial suspension of each isolate was seeded on either
Muller Hinton broth or agar plates by spreading method. The
antibiotic discs of ciprofloxacin, levofloxacin, Nalidixic acid,
norfloxacin and ofloxacin were applied and the plates were
incubated for overnight. The standard strain “P. aeruginosa
ATCC 27853™” was utilized for quality control of antibacterial
susceptibility test purpose. The findings were read based on
the CLSI and EUCAST 2018 Guidelines.
Plasmid DNA extraction: Plasmid DNA was extracted utilizing
QIAprep Spin Miniprep Kit (Catalogue No. 27104-QIAGEN)
according to the manufacture protocol. In brief, 2 mL of
overnight grown bacteria in LB broth was spun at 5000 rpm
for  10  min.  The  bacterial  cell  pellet  was  re-suspended  with
2 mL of TE buffer by vigorous shaking. About 0.4 mL of the
provided Lysis Buffer was added to the re-suspension and
mixed carefully. About 0.6 mL of cold Neutralization Buffer was
added to the mixture and then applied to the centre of the
spin column after converting the colour from blue to yellow by
inverting several times. The yellowish mixture was spun down
at 13,000 rpm for 1 min for removing retained lysate. After
washing with 400 µL of Wash Buffer at 13,000 rpm for 1 min,
the spin column was transferred into a 1.5 mL microfuge tube
for plasmid DNA elution by 40 µL TE buffer at 13,000 rpm
centrifugation for 2 min.
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Plasmid curing: Chemical-based sodium dodecyl sulphate
(SDS) method was adopted to eliminate the plasmid DNA
from  their  bacterial  hosts.  About 10  mL  Luria  Bertani  Broth 
(LB)  was  inoculated  with  a  single  colony  of  each  selected
P.  aeruginosa  isolate then incubated for overnight at 37EC in
a shaking incubator. About 0.1 mL of the culture was grown in
1 mL of 10% SDS in LB medium17. The plasmid curing
efficiency was confirmed by agarose gel electrophoresis. The
antibiotic susceptibility test of cured bacterial cells was carried
out.
Bacterial transformation with plasmid DNA: In order to gain
further evidence about the association of the genetic content
of plasmid DNA in augmentation of cellular resistance to
fluoroquinolones. One Shot TOP10 Competent E. coli  bacterial
cells (Catalogue No. C4040-03-Life technologies) were
transformed with the plasmid content based on the
manufacture protocol. Briefly, 2 µL of 50 ng µL plasmid DNA
was added into the competent E. coli  cells contained vial. The
mixture was incubated on ice for 30 min. Afterward, the cells
were exposed to heat-shock for 30 sec at 42EC without
shaking. The vial was re-incubated on ice for 2 min.
Subsequently, 500 µL of pre-warmed SOC broth was added to
the vial under sterilised conditions and then incubated in a
shaking incubator at 37EC for 1 h at 200 rpm. Finally, 100 µL
from transformation mixture was inoculated on a pre-warmed
selective medium plate  (Luria-Bertani  medium  contained
100 µg mLG1 ciprofloxacin).
Statistical analysis: Chi-squire tests were conducted for
statistical analyses of the study results, where p-values of less
than 0.05 have been considered as significant.
RESULTS
Based on the screening analysis, 67% of P. aeroginosa
isolates (n = 30) were detected in the collected clinical
specimens. The antimicrobial sensitivity test of the detected
isolates showed variable responses to the examined
fluoroquinolones   (ciprofloxacin,   levofloxacin,   norfloxacin
and  ofloxacin).  However,  the   common   susceptibility   trend
demonstrates that most of the isolates possess moderate to
high resistance to the studied antibiotics and Ciprofloxacin
was the more susceptible antibiotic to P. aeroginosa  (Table 1).
Based on their resistant to the selected antibiotic marker
(Ciprofloxacin),   the   most   resistant   P.  aeroginosa    isolates
(n = 6) were subjected for preliminary molecular analysis. The
plasmid DNA profiles of the selected isolates were
investigated. The results demonstrate that the examined
bacterial cells contain distinctive plasmid profiles ranged
between 6-2.5 kbp (Fig. 1).
In order to explore the implication of the plasmid DNA in
augmentation of fluoroquinolone resistance, the investigated
P. aeruginosa bacterial cells were subjected for eliminating
their plasmid content using SDS-based chemical treatments.
The agarose gel electrophoresis analysis revealed that the
plasmid curing was significantly efficient (p<0.05) with
elimination  rate  ranged  between 80-90%  (Fig.  2).  It  was
also illustrated from this figure that SDS-based chemical
method was efficient to eliminate the bacterial plasmid
content.   The  cured  daughter  P.  aeruginosa   cells  exhibited
Fig. 1: Gel    electrophoretic    figure    depicting    plasmid
profile extracted from the most ciprofloxacin resistant
P. aeroginosa  isolates
Electrophoretic lanes represent, 1 and 8: HyperLadder DNA markerand,
2-7: Plasmid DNA profiles of the examined P. aeroginosa  isolates, which
ranged between 6-2.5 kbp
Table 1: Susceptibility testing results of Fluoroquinolone antibiotics (Ciprofloxacin, Levofloxacin, Norfloxacin and Ofloxacin) alongside the zone diameter breakpoint
guide
Zone diameter breakpoint (mm) Susceptibility testing results
--------------------------------------------- -----------------------------------------------------------------------------------------
Fluoroquinolones Disk content (µg) S > I R < Susceptible strains Intermediate strains Resistant strains
Ciprofloxacin 5 26 25-17 16 6 (20%) 18 (40%) 6 (20%)
Levofloxacin 5 22 21-13 12 0 (0%) 17 (56.7%) 13 (43.3%)
Norfloxacin 10 17 13-16 12 3 (10%) 22 (73.3%) 5 (16.7%)
Ofloxacin 5 16 13-15 12 1 (3%) 19 (63.3%) 10 (33.3%)
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Fig. 2: Representative gel electrophoretic figure depicting
1: Plasmid removal from the daughter cells of the most ciprofloxacin
resistant  P.  aeroginosa  clinical  isolate  and  2:  Plasmid  DNA  of  the
parental P. aeroginosa  cells
Fig. 3: Variable resistance to ciprofloxacin among the
transformed E. coli  bacteria cells
Bars represent mean values of MIC from biological triplicates and error
bars represent 95% confidence intervals
higher response to ciprofloxacin among the tested
fluoroquinolones (ciprofloxacin, levofloxacin, norfloxacin and
ofloxacin).
In order to achieve further evidence to support the
hypothesis  that  the  plasmid  DNA   content   of   nosocomial
P.  aeruginosa  is implicated in raising the fluoroquinolones
resistance, bacterial transformation of E. coli  by the plasmid
DNA extracted from the most ciprofloxacin resistant isolates
(n = 6) has been carried out. Three successful transformed
clones of each plasmid extract were investigated for their
ciprofloxacin response. The findings proved the reduction of
ciprofloxacin response of successful transformed  E.  coli   cells.
On   the    other    hand,    the    ciprofloxacin    MIC    values    of
transformed E. coli cells were lower than that of plasmid
harbouring P. Aeruginosa  isolates (Fig. 3). The figure
illustrated  the  variable  resistance  to  ciprofloxacin  among
the  transformed   E.  coli   bacteria  significantly  higher  than
that of parental E. coli  and lower than that of P. aeruginosa.
DISCUSSION
Thirty  (67%)  P.  aeroginosa   isolates  were  detected  in
the collected specimens. The result indicated the high
prevalence of nosocomial P. aeroginosa in the screened
clinical specimens. The finding is in agreement with previous
reports that confirm the high prevalence of P. aeruginosa
casing hospital acquired infections during the last three
decades1,18-20. In fact, the examined isolates manifested
moderate to high resistance to the tested fluoroquinolone,
which could be an indicator for higher expression levels of
quinolones resistance regulated genes8,14,21. Exploring the
plasmid DNA  content  of  the  most  resistant  isolates
uncovered distinguishing profiles ranged between 6-2.5 kpb.
The outcome coincides with previous studies22,23.
The evidence achieved from exploring the implication of
the plasmid content in augmentation of fluoroquinolone
resistance by plasmid curing clearly explain that the
elimination of the plasmid profile modulate the cured resistant
isolates to be fluoroquinolone sensitive forms. Therefore, the
plasmid DNA content might be directly implicated in
increasing antibiotic resistance to fluoroquinolones in the
clinical isolates of burn wounds14,23.
Towards exploring further evidence to support the
potential role of P. aeruginosa plasmids in emergence
fluoroquinolones resistance,  bacterial  transformation strategy
was adopted. Transformed E. coli cells by P. aeruginosa
plasmids revealed significant increase in their resistance to
ciprofloxacin (p<0.05) compared to the non-transformed
parental   E.   coli,   although   the   ciprofloxacin   MIC  values
of transformed cells were lower than that of plasmid
harbouring P.  aeruginosa  cells  (Fig.  3).  In  view  of  the  fact
that the quinolone resistance factors are chromosomally
regulated24-26,  the  difference  in  ciprofloxacin  response
between  P.  aeruginosa   and   transformed   bacteria  shown
in   Fig.   3   could   be   explained   by   additive   impact   by
both   plasmid   and   chromosomal   gene   expression   of
either  topoisomerase  IV  and  gyrase  enzymes  or  efflux
pump  factors  in  wild  type  P.  aeruginosa  bacteria  as  being
up-regulated  in  fluoroquinolone   resistant   bacteria27.  Such
an  additive  ciprofloxacin  resistant  was  previously  observed
in   E.   coli 28,29.   As    a    result,   transformed    E.    coli    clones’
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responded slightly higher to ciprofloxacin than that of wild
type P. aeruginosa, where the chromosomal associated
resistance is lacked. This study may help in future for further
molecular investigation of plasmid-mediated fluoroquinolone
resistance in P. aeruginosa15,30.
CONCLUSION
Taken together both of achieved evidence from plasmid
curing  and  E.  coli   transformation  studies,  the   outcome
was  clearly  uncovered  the  significant  impact  of  plasmid
DNA   in   elevating   ciprofloxacin   resistance   in   nosocomial
P. aeruginosa  isolates. Thus, the plasmid profile may foresee
fluoroquinolone response in patients with hospitalized
acquired pseudomonal infections in the Iraqi medical centres.
Nevertheless, this study requires further molecular analysis on
a larger sample size.
SIGNIFICANCE STATEMENT
This study discovers the association between plasmid
DNA  content  and  fluoroquinolone  resistance  of  nosocomial
P. aeruginosa  that can be beneficial for stratifying patients
with hospitalised acquired pseudomonal infections for
ciprofloxacin-based regimen. This study will help the
researcher to uncover the critical areas of molecular
investigation of plasmid-mediated fluoroquinolone resistance
in P. aeruginosa  that many researchers were not able to
explore. Thus a new theory on plasmid-based fluoroquinolone
personalized treatment of nosocomial P. aeruginosa 
infections may be arrived at.
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